These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6318344)

  • 1. [The bioavailability of ketoprofen (Profenid) administered orally in combination with a gastric protector (aluminum phosphate, Phosphalugel)].
    Tamisier JN; Brazier JL; Ambert D; Bannier A
    Sem Hop; 1983 Dec; 59(46):3214-7. PubMed ID: 6318344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioavailability of ketoprofen in man with and without concomitant administration of aluminium phosphate.
    Brazier JL; Tamisier JN; Ambert D; Bannier A
    Eur J Clin Pharmacol; 1981 Mar; 19(4):305-7. PubMed ID: 7286034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of meal size and composition on the bioavailability of ketoprofen (Oruvail).
    Nievel JG; Havard CW; Mitchell P; Gudgeon A; Kaye CM
    Xenobiotica; 1987 Apr; 17(4):487-92. PubMed ID: 3604255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetics of ketoprofen in the synovial fluid].
    Kennedy AC
    Sem Hop; 1983 Dec; 59(46):3208-9. PubMed ID: 6318342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chronokinetics of ketoprofen administered orally and by continuous venous infusion].
    Queneau P; Decousus H; Ollagnier M; Cherrah Y; Perpoint B; Hocquart J
    Rev Rhum Mal Osteoartic; 1985 Jun; 52(6):403-8. PubMed ID: 4048810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pharmacokinetic study of repeated doses of a new controlled release form of ketoprofen.
    Houghton GW; Dennis MJ; Templeton R; Calvert RM; Cresswell DG
    Int J Clin Pharmacol Ther Toxicol; 1984 Mar; 22(3):131-3. PubMed ID: 6715081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study on the absorption of ketoprofen topically administered in man: comparison between tissue and plasma levels.
    Ballerini R; Casini A; Chinol M; Mannucci C; Giaccai L; Salvi M
    Int J Clin Pharmacol Res; 1986; 6(1):69-72. PubMed ID: 3957503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Open clinical trial of a new oral galenic form of ketoprofen].
    Huck F; Lecocq J; Meyer R; Kuntz JL; Asch L
    Sem Hop; 1983 Dec; 59(46):3240-2. PubMed ID: 6318350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetic profile of a slow-release ketoprofen preparation].
    Flouvat B; Stheneur A; Massias P
    Sem Hop; 1983 Dec; 59(46):3187-90. PubMed ID: 6318337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of ketoprofen in man after repeated percutaneous administration.
    Flouvat B; Roux A; Delhotal-Landes B
    Arzneimittelforschung; 1989 Jul; 39(7):812-5. PubMed ID: 2783185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circadian changes in the pharmacokinetics of oral ketoprofen.
    Ollagnier M; Decousus H; Cherrah Y; Levi F; Mechkouri M; Queneau P; Reinberg A
    Clin Pharmacokinet; 1987 May; 12(5):367-78. PubMed ID: 3608343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adverse effects of ketoprofen on the gastroduodenal mucosa. Comparison of the 2 oral forms].
    Barthélémy C
    Sem Hop; 1983 Dec; 59(46):3258-60. PubMed ID: 6318355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of ketoprofen bioavailability by formation of microsponge tablets.
    Comoglu T; Savaşer A; Ozkan Y; Gönül N; Baykara T
    Pharmazie; 2007 Jan; 62(1):51-4. PubMed ID: 17294814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability study on a new slow-release formulation of ketoprofen.
    Caruso I; Frigerio E; Fumagalli M; Liverta C; Moro L; Tamassia V
    J Int Med Res; 1982; 10(4):229-33. PubMed ID: 7117681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic study of ketoprofen (19.583 R.P.) in man using the tritiated compound.
    Delbarre F; Roucayrol JC; Amor B; Ingrand J; Bourat G; Fournel J; Courjaret J
    Scand J Rheumatol Suppl; 1976; 1976(0):45-52. PubMed ID: 1068515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of antacid and aspirin on the bioavailability of isofezolac in man.
    Rocher I; Henry JF; Flouvat B
    Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):464-9. PubMed ID: 6500763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of a slow-release preparation of ketoprofen lysine in man.
    Borsa M; Tonon GC; Ronchi C; Zanolo G; Canali S
    Arzneimittelforschung; 1983; 33(10):1497-500. PubMed ID: 6418181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Species comparison of enantioselective oral bioavailability and pharmacokinetics of ketoprofen.
    Neirinckx E; Croubels S; De Boever S; Remon JP; Bosmans T; Daminet S; De Backer P; Vervaet C
    Res Vet Sci; 2011 Dec; 91(3):415-21. PubMed ID: 20961590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ketoprofen-aspirin interaction].
    Pawlotsky Y; Louboutin JY; Chales G; Flouvat B; Roux A
    Sem Hop; 1983 Dec; 59(46):3218-20. PubMed ID: 6318345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.